The Pharmacological Effects of Silver Nanoparticles Functionalized with Eptifibatide on Platelets and Endothelial Cells

The Pharmacological Effects of Silver Nanoparticles Functionalized with Eptifibatide on Platelets and Endothelial Cells

Justyna Hajtuch,1 Eliza Iwicka,1 Anna Szczoczarz,1 Damian Flis,1 El&zdot;bieta Megiel,2 Piotr Cieciórski,2 Marek Witold Radomski,3 Maria Jose Santos-Martinez,4 Iwona Inkielewicz-Stepniak1 1Department of Pharmaceutical Pathophysiology, Medical University of Gdansk, Gdansk, Poland; 2Faculty of Che...

Full description

Bibliographic Details
Main Authors:	Hajtuch J, Iwicka E, Szczoczarz A, Flis D, Megiel E, Cieciórski P, Radomski MW, Santos-Martinez MJ, Inkielewicz-Stepniak I
Format:	Article
Language:	English
Published:	Dove Medical Press 2022-09-01
Series:	International Journal of Nanomedicine
Subjects:	drug delivery antiplatelet rgd aggregation coagulation system biocompatibility
Online Access:	https://www.dovepress.com/the-pharmacological-effects-of-silver-nanoparticles-functionalized-wit-peer-reviewed-fulltext-article-IJN

Similar Items

Effects of functionalized silver nanoparticles on aggregation of human blood platelets
by: Hajtuch J, et al.
Published: (2019-09-01)

Pharmacological and toxicological effects of co-exposure of human gingival fibroblasts to silver nanoparticles and sodium fluoride
by: Inkielewicz-Stepniak I, et al.
Published: (2014-04-01)

Initial osteoblast adhesion and subsequent differentiation on zirconia surfaces are regulated by integrins and heparin-sensitive molecule
by: Luo F, et al.
Published: (2018-11-01)

Muramyl dipeptide-based analogs as potential anticancer compounds: Strategies to improve selectivity, biocompatibility, and efficiency
by: Eliza Iwicka, et al.
Published: (2022-09-01)

Ticagrelor and Eptifibatide Bolus Versus Ticagrelor and Eptifibatide Bolus With 2‐Hour Infusion in High‐Risk Acute Coronary Syndromes Patients Undergoing Early Percutaneous Coronary Intervention
by: Moazez J. Marian, et al.
Published: (2017-11-01)

Lipoic Acid-Coated Silver Nanoparticles: Biosafety Potential on the Vascular Microenvironment and Antibacterial Properties
by: Justyna Hajtuch, et al.
Published: (2022-01-01)

Alterations in platelets during SARS-CoV-2 infection
by: Marta Brambilla, et al.
Published: (2022-02-01)

Biodegradable small-diameter vascular graft: types of modification with bioactive molecules and RGD peptides
by: E. A. Senokosova, et al.
Published: (2020-04-01)

Eptifibatide, an Older Therapeutic Peptide with New Indications: From Clinical Pharmacology to Everyday Clinical Practice
by: Gašper Tonin, et al.
Published: (2023-03-01)

The Synthesis and Evaluation of RGD−Conjugated Chitosan Gel as Daily Supplement for Body Weight Control
by: Wei-Yao Chen, et al.
Published: (2021-08-01)

Peptide-Conjugated Quantum Dots Act as the Target Marker for Human Pancreatic Carcinoma Cells
by: Shuang-ling Li, et al.
Published: (2016-03-01)

Effects of Antiplatelet Drugs on Platelet-Dependent Coagulation Reactions
by: Ivan A. Muravlev, et al.
Published: (2023-07-01)

Silver Nanoparticles as Chlorhexidine and Metronidazole Drug Delivery Platforms: Their Potential Use in Treating Periodontitis [Corrigendum]
by: Steckiewicz KP, et al.
Published: (2023-03-01)

Inhibitory effect of various Thai natural plants ethanolic extracts on platelet aggregation and blood coagulation in vitro
by: Suwit Duangmano, et al.
Published: (2016-01-01)

Modified Nanoparticles as Potential Agents in Bone Diseases: Cancer and Implant-Related Complications
by: Karol P. Steckiewicz, et al.
Published: (2020-04-01)

Design Methods of Cell Adhesion Proteins Based on ELISA Usable in-vitro in Gene Therapy
by: E Hosseini, et al.
Published: (2016-07-01)

Biological and Clinical Consequences of Integrin Binding via a Rogue RGD Motif in the SARS CoV-2 Spike Protein
by: Lee Makowski, et al.
Published: (2021-01-01)

DENTAL MANAGEMENT AND BLEEDING COMPLICATIONS OF PATIENTS ON LONG-TERM ORAL ANTIPLATELET THERAPY. REVIEW OF EXISTING STUDIES AND GUIDELINES.
by: Atanaska Dinkova, et al.
Published: (2013-06-01)

Pharmacologic inhibition of RGD‐binding integrins ameliorates fibrosis and improves function following kidney injury
by: Jeannine Basta, et al.
Published: (2020-04-01)

Platelet antiaggregants in the treatment and prevention of ischemic stroke
by: Andrei Viktorovich Fonyakin
Published: (2013-12-01)

SHR2285, the first selectively oral FXIa inhibitor in China: Safety, tolerability, pharmacokinetics and pharmacodynamics combined with aspirin, clopidogrel or ticagrelor
by: Tingting Ma, et al.
Published: (2022-10-01)

DENTAL CONSIDERATIONS IN PATIENTS TAKING NEW ANTIPLATELET AND ANTICOAGULANT DRUGS
by: Atanaska S. Dinkova, et al.
Published: (2020-05-01)

Anti-Platelet Fraction Isolated from Galega Officinalis
by: Atanasov A.
Published: (2016-10-01)

Targeting Platelets for the Treatment of Cancer
by: Omar Elaskalani, et al.
Published: (2017-07-01)

<sup>225</sup>Ac-iPSMA-RGD for Alpha-Therapy Dual Targeting of Stromal/Tumor Cell PSMA and Integrins
by: Blanca Ocampo-García, et al.
Published: (2023-11-01)

Biocompatibility of Surface-Modified Membranes for Chronic Hemodialysis Therapy
by: Mario Bonomini, et al.
Published: (2022-04-01)

Abstract 1122‐000231: A Review of Effect of Ticagrelor on Platelet Inhibition in Clopidogrel Non‐Responders Undergoing Neuroendovascular Procedure
by: Priyadarshee PATEL, et al.
Published: (2021-11-01)

Molecular Mechanism of Silver Nanoparticles-Induced Human Osteoblast Cell Death: Protective Effect of Inducible Nitric Oxide Synthase Inhibitor.
by: Ewelina Zielinska, et al.
Published: (2016-01-01)

Silver Nanoparticles Densely Grafted with Nitroxides as a Recyclable Green Catalyst in the Selective Oxidation of Alcohols
by: Agnieszka Krogul-Sobczak, et al.
Published: (2022-07-01)

Engineering of Doxorubicin-Encapsulating and TRAIL-Conjugated Poly(RGD) Proteinoid Nanocapsules for Drug Delivery Applications
by: Elad Hadad, et al.
Published: (2020-12-01)

In vitro assessment of the cytotoxic effects of novel RGD analogues
by: Anelia Balacheva, et al.
Published: (2012-10-01)

iRGD Peptide as a Tumor-Penetrating Enhancer for Tumor-Targeted Drug Delivery
by: Sujin Kang, et al.
Published: (2020-08-01)

Change of Platelet Reactivity to Antiplatelet Therapy after Stenting Procedure for Cerebral Artery Stenosis: VerifyNow Antiplatelet Assay before and after Stenting
by: Deok Hee Lee, et al.
Published: (2012-02-01)

Platelet reactivity in dyslipidemia: atherothrombotic signaling and therapeutic implications
by: Moua Yang, et al.
Published: (2021-03-01)

Synthesis of Imine Congeners of Resveratrol and Evaluation of Their Anti-Platelet Activity
by: Mohammad Bigdeli, et al.
Published: (2018-12-01)

Can Isoquinoline Alkaloids Affect Platelet Aggregation in Whole Human Blood?
by: Mst Shamima Parvin, et al.
Published: (2022-07-01)

Multimeric RGD-Based Strategies for Selective Drug Delivery to Tumor Tissues
by: Jordan Cossu, et al.
Published: (2023-02-01)

Investigation of interaction of human platelet membrane components with anticoagulant drugs Abciximab and Eptifibatide
by: Ewa Gorodkiewicz, et al.
Published: (2010-04-01)

Dual antiplatelet therapy is associated with high α-tubulin acetylation in circulating platelets from coronary artery disease patients
by: Valentine Robaux, et al.
Published: (2023-12-01)

Atractylodes lactone compounds inhibit platelet activation
by: Yizhu Chen, et al.
Published: (2017-02-01)